Results 41 to 48 of about 76 (48)

The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases. [PDF]

J Neuroimmunol, 2021
Cama VF, Marín-Prida J, Acosta-Rivero N, Acosta EF, Díaz LO, Casadesús AV, Fernández-Marrero B, Gilva-Rodríguez N, Cremata-García D, Cervantes-Llanos M, Piniella-Matamoros B, Sánchez D, Del Rosario-Cruz L, Borrajero I, Díaz A, González Y, Pentón-Arias E, Montero-González T, Guillen-Nieto G, Pentón-Rol G.   +19 more
europepmc   +1 more source

Aportes del estudio de 800 autopsias de pacientes con la COVID-19 en Cuba

Revista Cubana de Medicina Militar
Introducción: En el año 2020 una nueva enfermedad se transformó en una pandemia. En Cuba se elaboró una metodología segura para su estudio morfológico.
José Domingo Hurtado de Mendoza Amat, Teresita Montero González , Virginia Capó de Paz , Laura López Marín , Licet González Fabián   +4 more
doaj  

Citrullinated peptides as drug candidates for rheumatoid arthritis. [PDF]

Front Immunol
Bustos AH, Brüner M, Kragstrup TW, Astakhova K.   +3 more
europepmc   +1 more source

Synergistic Anti-Inflammatory Activity of Lipid-Free Apolipoprotein (apo) A-I and CIGB-258 in Acute-Phase Zebrafish via Stabilization of the apoA-I Structure to Enhance Anti-Glycation and Antioxidant Activities. [PDF]

Int J Mol Sci
Cho KH, Bahuguna A, Lee Y, Lee SH, Dominguez-Horta MDC, Martinez-Donato G.   +5 more
europepmc   +1 more source

Synergistic Anti-Inflammatory Activity of Apolipoprotein A-I and CIGB-258 in Reconstituted High-Density Lipoproteins (rHDL) against Acute Toxicity of Carboxymethyllysine in Zebrafish and Its Embryo. [PDF]

Pharmaceuticals (Basel)
Cho KH, Kim JE, Kang DJ, Dominguez-Horta MDC, Martinez-Donato G.   +4 more
europepmc   +1 more source

Molecular Chaperonin HSP60: Current Understanding and Future Prospects. [PDF]

Int J Mol Sci
Singh MK, Shin Y, Han S, Ha J, Tiwari PK, Kim SS, Kang I.   +6 more
europepmc   +1 more source

Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match. [PDF]

BMJ Glob Health
Cokljat M, Cruz CV, Carrara VI, Puttaraksa K, Capriglioni C, Insaurralde SM, Rousseau-Portalis M, Roldan A, Watson JA, Tarning J, White NJ, Guerin PJ.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Caracterización de la unión entre Jusvinza y la Apolipoproteína A-I

Jusvinza es un fármaco inmunomodulador diseñado para el tratamiento de enfermedades autoinmunitarias. Este medicamento ha resultado eficaz en disminuir la inflamación de pacientes con Artritis Reumatoide (AR) y COVID-19 (del inglés Coronavirus Disease 2019) (Prada y col., 2018; Baldomero y col., 2020; Venegas y col., 2023).
openaire